CaMaPi for Adolescents/Young People With a History of Self-harm and Suicidal Ideation in Jos, Nigeria (CaMaPi)

Culturally-adapted Manual-assisted Psychological Intervention (CaMaPi) for Adolescents/Young People With a History of Self-harm and Suicidal Ideation in Jos, Nigeria

Suicide and self-harm are global disease burden that contributes significantly to years of lost life and mortality.

Study Overview

• Status: Not yet recruiting
• Conditions: Suicidal Ideation; Self-harm
• Intervention / Treatment: Behavioral: CaMaPi; Other: TAU

Detailed Description

Self-harm and suicidal ideation represent a significant global public health concern (Knipe et al., 2022), affecting about 14.6 million people yearly (Nichols et al., 2021). Globally, over 700 000 people die by suicide annually (World Health Organization -- WHO, 2023).

Suicide is the fourth leading cause of death among 15-29-year-olds, and 77% of global suicides occur in low- and middle-income countries, including Nigeria (WHO, 2023). The psychological impact of suicidal ideation includes continuing high tendencies of self-harm (Jidong et al., 2024).

Despite the increasing rates of suicide and self-harm in Nigeria, this topic is understudied, with no culturally appropriate or sustainable psychological interventions.

• Study Type: Interventional
• Enrollment (Estimated): 32
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Dung Jidong, PhD; Phone Number: +44 07448930519; Email: dung.jidong@mamnchester.ac.uk

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Patients aged 16-24 years presenting to the participating services, and emergency departments or admitted after an episode of self-harm to the participating hospitals or self-referrals.
• Participants will have to be living within the catchment area of the participating practices, services and hospitals.
• Not needing inpatient psychiatric treatment.

Exclusion Criteria:

• Severe mental illness (such as Psychotic disorder).
• Conditions limiting engagement with assessment/intervention.
• Temporary resident unlikely to be available for follow up.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: TAU	Other: TAU; Treatment as Usual (TAU) is routine care, such as diagnosis, assessment, psychotherapy, monitoring and any form of intervention (e.g., medication prescription) available at the collaborating service.
Experimental: CaMaPi	Behavioral: CaMaPi; CaMaPi is a manually assisted brief psychological intervention that is based on the principles of Cognitive Behaviour Therapy (CBT). The intervention includes psycho-education and a comprehensive cognitive behavioural assessment of the suicidal ideation and self-harm attempt using virtual stories of four young people to be delivered in 8-10 sessions for over three months

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in acceptance and satisfaction with the intervention	Primary outcome measure would be assessed using the Service Satisfaction Scale	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in suicidal ideation	Secondary outcome measure would be assessed using the Beck Scale for Suicide Ideation	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention
Change in hopelessness	Secondary outcome measure would be assessed using the Beck Hopelessness Scale	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention
Change in Health Status	Secondary outcome measure would be assessed using the EQ-5D-5L quality of health scale	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention
Change in repetition rate's of self-harm	Secondary outcome measure would be assessed using an adapted Suicide Attempt Self-Injury Interview	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention
Change in use of health services	Secondary outcome measure would be assessed using Client Service Receipt Inventory	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention
Change in psychological distress	Secondary outcome measure would be assessed using Kessler Psychological Distress Scale	Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention

Collaborators and Investigators

• Sponsor: Nottingham Trent University
• Collaborators: University of Manchester; Teesside University; Jos University Teaching Hospital

Study record dates

Study Major Dates

• Study Start (Estimated): July 1, 2024
• Primary Completion (Estimated): June 30, 2025
• Study Completion (Estimated): September 30, 2025

Study Registration Dates

• First Submitted: May 28, 2024
• First Submitted That Met QC Criteria: May 28, 2024
• First Posted (Actual): June 3, 2024

Study Record Updates

• Last Update Posted (Actual): June 3, 2024
• Last Update Submitted That Met QC Criteria: May 28, 2024
• Last Verified: May 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Behavioral Symptoms; Suicide; Suicidal Ideation; Self-Injurious Behavior
• Other Study ID Numbers: 0000-0001-5034-0335f

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No